Cure8 news brief
This trial suggests a structured whole-food diet may reduce subclinical intestinal inflammation (measured by fecal calprotectin) in asymptomatic children and young adults with Crohn's disease—offering a non-formula, food-based adjunct to medical care.
Patients with Crohn's disease who have elevated calprotectin despite being symptom-free, parents/caregivers of pediatric patients, dietitians and clinicians managing IBD, and researchers interested in diet-based interventions for IBD.
This was a randomized controlled trial (TASTI-E) in children and young adults (ages 6–40) with biologic evidence of mucosal inflammation but without active symptoms. The primary outcome was a >50% decline in fecal calprotectin; 53% of patients randomized to T&H met that threshold versus 7% on a habitual diet.
The habitual-diet group was later offered the T&H diet in an open-label crossover, with additional patients showing calprotectin and MINI improvements after crossing over. The intervention is a formula-free whole-food approach that led to higher fiber intake and a distinct serum metabolic signature; adherence was reported as high.
The study was terminated early because of COVID-19–related challenges and enrolled 46 participants, which affects the strength and generalizability of the results. Practical note: The authors highlight the need for personalized dietary counseling to ensure adequate calcium and other micronutrient intake, since both groups fell below recommended levels.
The study was small and stopped early for COVID-19 reasons; results come from a specific age range (6–40 years) and patients with subclinical inflammation. The article summarizes a published Clinical Gastroenterology and Hepatology trial (ClinicalTrials.gov NCT04239248). This is promising but not definitive proof of long-term clinical benefit.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Diet quality was linked to gut microbiome features and exploratory differences in inflammatory markers and symptoms in adults with Crohn disease from Puerto Rico; understanding these links may help tailor dietary...
This study suggests that higher intake of specific fibers (beta‑glucan and inulin) may be linked to lower Crohn’s risk in people with a family history, and it connects those fibers to biomarkers of inflammation, barrier...
Both EEN and the Crohn’s disease exclusion diet are used to induce remission in children with Crohn’s disease. Evidence that they perform similarly through 52 weeks may help families and clinicians choose the approach...
